{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03787602",
            "orgStudyIdInfo": {
                "id": "KRT-232-103"
            },
            "organization": {
                "fullName": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma",
            "officialTitle": "A Phase 1b/2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients With p53 Wild-Type (p53WT) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination With Avelumab in MCC Patients Who Are Anti-PD-1 or Anti-PD-L1 Treatment Na\u00efve",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "navtemadlin-krt-with-or-without-anti-pd-anti-pd-for-the-treatment-of-patients-with-merkel-cell-carcinoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-03-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-12-06",
            "studyFirstSubmitQcDate": "2018-12-21",
            "studyFirstPostDateStruct": {
                "date": "2018-12-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-02-28",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Merkel Cell Carcinoma (MCC) who have failed treatment with at least one anti-PD-1 or anti-PD-L1 immunotherapy or in combination with avelumab in MCC patients who are anti-PD-1 or anti-PD-L1 treatment na\u00efve. Inhibition of MDM2 is a novel mechanism of action in MCC."
        },
        "conditionsModule": {
            "conditions": [
                "Merkel Cell Carcinoma"
            ],
            "keywords": [
                "navtemadlin (KRT-232)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 115,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1, Arm 1",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 21-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 1, Arm 1b",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-5 in a 23-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 1, Arm 2b",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-5 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 1, Arm 3",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 21-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 1, Arm 5",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 1 Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) per Cohort 1 RP2D dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 2, Arm 1 KRT-232 in combination with avelumab",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-5, in combination with avelumab 800 mg IV on Day 1 and 15 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Avelumab"
                    ]
                },
                {
                    "label": "Cohort 2, Arm 2 KRT-232 in combination with avelumab",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7, in combination with avelumab 800 mg IV on Day 1 and 15 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Avelumab"
                    ]
                },
                {
                    "label": "Cohort 2 Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) per RP2D dose and schedule, in combination with avelumab 800 mg IV on Day 1 and 15 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Avelumab"
                    ]
                },
                {
                    "label": "Cohort 3",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) per Cohort 1 RP2D dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                },
                {
                    "label": "Cohort 4",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) per Cohort 1 RP2D dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "KRT-232",
                    "description": "KRT-232 is an experimental MDM2 anticancer drug taken by mouth.",
                    "armGroupLabels": [
                        "Cohort 1 Expansion",
                        "Cohort 1, Arm 1",
                        "Cohort 1, Arm 1b",
                        "Cohort 1, Arm 2b",
                        "Cohort 1, Arm 3",
                        "Cohort 1, Arm 5",
                        "Cohort 2 Expansion",
                        "Cohort 2, Arm 1 KRT-232 in combination with avelumab",
                        "Cohort 2, Arm 2 KRT-232 in combination with avelumab",
                        "Cohort 3",
                        "Cohort 4"
                    ],
                    "otherNames": [
                        "navtemadlin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Avelumab",
                    "description": "Avelumab is a PD-L1 blocking antibody anticancer drug administered by intravenous infusion.",
                    "armGroupLabels": [
                        "Cohort 2 Expansion",
                        "Cohort 2, Arm 1 KRT-232 in combination with avelumab",
                        "Cohort 2, Arm 2 KRT-232 in combination with avelumab"
                    ],
                    "otherNames": [
                        "Bavencio"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Cohort 1 Part 1: To determine the KRT-232 RP2D.",
                    "description": "The Safety Review Committee (SRC) will determine RP2D for expansion based on safety and tolerability of each arm.",
                    "timeFrame": "10 Weeks"
                },
                {
                    "measure": "Cohort 1 Part 2: To determine the objective response rate (ORR) in subjects with p53WT MCC who have failed anti-PD-1 or anti-PDL-1 immunotherapy",
                    "description": "ORR will be assessed per RECIST criteria version 1.1 after all subjects have been treated at the RP2D of KRT 232 and completed the second response assessment.",
                    "timeFrame": "10 Weeks"
                },
                {
                    "measure": "Cohort 2 Part 1: To determine the KRT-232 RP2D in combination with avelumab",
                    "description": "DLTs will be used to establish the MTD of KRT-232 in combination with avelumab. SRC will determine the RP2D based on the safety of combination of KRT-232 with avelumab.",
                    "timeFrame": "28 Days"
                },
                {
                    "measure": "Cohort 2 Part 2: To determine the objective response rate (ORR) in treatment-na\u00efve subjects with p53WT MCC",
                    "description": "ORR will be assessed per RECIST criteria version 1.1 after all 30 subjects have been treated at the RP2D of in combination with avelumab and have completed the second response assessment.",
                    "timeFrame": "10 Weeks"
                },
                {
                    "measure": "Cohort 3: To determine the confirmed overall response rate (ORR) based on IRC assessments in subjects with p53WT MCC are chemotherapy naive and have failed anti-PD-1/PD-L.",
                    "description": "ORR will be assessed per RECIST criteria 1.1 by IRC.",
                    "timeFrame": "10 Weeks"
                },
                {
                    "measure": "Cohort 4: To determine the confirmed overall response rate (ORR) based on IRC assessments in subjects with p53WT MCC who have failed anti-PD-1 or anti-PDL-1 immunotherapy and have had least 1 line of prior chemotherapy.",
                    "description": "ORR will be assessed per RECIST criteria 1.1 by IRC.",
                    "timeFrame": "10 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To determine the confirmed ORR based on investigator assessment.",
                    "description": "ORR will be assessed per RECIST criteria 1.1 by investigators.",
                    "timeFrame": "1 year after last subject enrolled."
                },
                {
                    "measure": "To determine the duration of response (DoR)",
                    "description": "Time from documentation of response (CR or PR as determined by RECIST 1.1) until disease progression.",
                    "timeFrame": "1 year after last subject enrolled"
                },
                {
                    "measure": "To determine Progression-free survival (PFS)",
                    "description": "Time from initial treatment until disease progression.",
                    "timeFrame": "1 year after last subject enrolled"
                },
                {
                    "measure": "To determine overall survival (OS)",
                    "description": "Time from initial treatment until death from any cause.",
                    "timeFrame": "1 year after last subject enrolled"
                },
                {
                    "measure": "To determine clinical benefit rate (CBR)",
                    "description": "PR, CR or stable disease that last at least 10 weeks, per IRC or investigator assessment.",
                    "timeFrame": "1 year after last subject enrolled."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* For Cohort 1, 3 and 4 patients must have failed treatment with at least one PD-1 inhibitor or PD-L1 inhibitor for metastatic MCC\n* For Cohort 2, patients must not have received any anti-PD-1 or anti-PD-L1 therapy\n* For Cohort 3, patients must not have received any prior chemotherapy\n* For Cohort 4, patients must have received at least one prior line of chemotherapy\n* ECOG performance status of 0 to 1\n* Histologically confirmed MCC. Disease must be measurable, with at least 1 measurable lesion by RECIST 1.1\n* MCC expressing p53WT based on any CLIA or test approved by local health authority or a validated test (Cohort 1 and 2)\n* MCC expressing p53WT based Central Lab test (Cohort 3 and 4)\n* Adequate hematological, hepatic, and renal functions\n\nExclusion Criteria:\n\n* For Cohort 2, subjects must not have autoimmune disease, medical conditions requiring systemic immunosuppression, prior stem cell transplant, or active infection with HBV or HCV.\n* Patients previously treated with MDM2 antagonist therapies or p53-directed therapies\n* History of major organ transplant\n* Patients with known central nervous system (CNS) metastases that are previously untreated\n* Grade 2 or higher QTc prolongation (\\>480 milli-seconds per NCI-CTCAE criteria, version 5.0)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John Mei",
                    "role": "CONTACT",
                    "phone": "650-542-0136",
                    "email": "jmei@kartosthera.com"
                },
                {
                    "name": "Emily Houlihan",
                    "role": "CONTACT",
                    "phone": "401-954-8042",
                    "email": "ehoulihan@kartosthera.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz Medical Campus",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Miami Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33176",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Moffitt",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Northwestern Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Norton Healthcare",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Norton Cancer Institute Research",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana-Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215-5418",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Memorial Sloan-Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Mount Sinai Hospital",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Fox Chase Cancer Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19111-2434",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "UPMC Hillman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "University of Texas MD Anderson",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Inova Health Care Services",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Princess Alexandra Hospital Oncology",
                    "status": "RECRUITING",
                    "city": "Woolloongabba",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.48855,
                        "lon": 153.03655
                    }
                },
                {
                    "facility": "Centro Catarinense de Pesquisa (CECAP) - Hospital Santa Catarina de Blumenau",
                    "status": "RECRUITING",
                    "city": "Blumenau",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -26.91944,
                        "lon": -49.06611
                    }
                },
                {
                    "facility": "Instituto Nacional do Cancer",
                    "status": "RECRUITING",
                    "city": "Bras\u00edlia",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -15.77972,
                        "lon": -47.92972
                    }
                },
                {
                    "facility": "Centro Intergado de Oncologia",
                    "status": "RECRUITING",
                    "city": "Curitiba",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -25.42778,
                        "lon": -49.27306
                    }
                },
                {
                    "facility": "Centro de Pesquisa Clinica em Oncologia",
                    "status": "RECRUITING",
                    "city": "Iju\u00ed",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -28.38778,
                        "lon": -53.91472
                    }
                },
                {
                    "facility": "Clinica De Neoplasias Litoral",
                    "status": "RECRUITING",
                    "city": "Itajai",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -26.90778,
                        "lon": -48.66194
                    }
                },
                {
                    "facility": "Hospital Paulistano",
                    "status": "RECRUITING",
                    "city": "S\u00e3o Paulo",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "CHU de Bordeaux- Hopital Saint-Andre",
                    "status": "RECRUITING",
                    "city": "Bordeaux",
                    "country": "France",
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "AP-HP Universite Paris Saclay",
                    "status": "RECRUITING",
                    "city": "Gif-sur-Yvette",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.68333,
                        "lon": 2.13333
                    }
                },
                {
                    "facility": "CHU de Lille",
                    "status": "RECRUITING",
                    "city": "Lille",
                    "country": "France",
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "CHU Lyon-Sud",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "H\u00f4pital de la Timone. Aix-Marseille Universit\u00e9",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "Cedex 5",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "CHU Montpellier",
                    "status": "RECRUITING",
                    "city": "Montpellier",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.61092,
                        "lon": 3.87723
                    }
                },
                {
                    "facility": "CHU de Nantes",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "H\u00f4pital Saint Louis - APHP",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "CHU de Tours",
                    "status": "RECRUITING",
                    "city": "Tours",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.38333,
                        "lon": 0.68333
                    }
                },
                {
                    "facility": "Vivantes Network for Health Gmb, Neuk\u00f6lln Clinic",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Erlangen",
                    "status": "RECRUITING",
                    "city": "Erlangen",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.59099,
                        "lon": 11.00783
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Essen (A\u00f6R)",
                    "status": "RECRUITING",
                    "city": "Essen",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Nationales Centrum f\u00fcr Tumorerkrankungen NCT",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.40768,
                        "lon": 8.69079
                    }
                },
                {
                    "facility": "Uniklinik Koln",
                    "status": "RECRUITING",
                    "city": "K\u00f6ln",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.93333,
                        "lon": 6.95
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinik Rostock",
                    "status": "RECRUITING",
                    "city": "Rostock",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 54.0887,
                        "lon": 12.14049
                    }
                },
                {
                    "facility": "Universitats-Hautklinik Tubingen",
                    "status": "RECRUITING",
                    "city": "T\u00fcbingen",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.52266,
                        "lon": 9.05222
                    }
                },
                {
                    "facility": "Institute for Cancer Research and Treatment",
                    "status": "RECRUITING",
                    "city": "Candiolo",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.95858,
                        "lon": 7.59812
                    }
                },
                {
                    "facility": "Istituto Nazionale Tumori IRCCS Fondazione Pascale",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "AUSL della Romagna",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "AOUS Le Scotte",
                    "status": "RECRUITING",
                    "city": "Siena",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.31822,
                        "lon": 11.33064
                    }
                },
                {
                    "facility": "OSP Civile Maggiore Borgo Trento",
                    "status": "RECRUITING",
                    "city": "Verona",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.4299,
                        "lon": 10.98444
                    }
                },
                {
                    "facility": "National Cancer Center",
                    "status": "RECRUITING",
                    "city": "Goyang-si",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.65639,
                        "lon": 126.835
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital Yonsei University Health System",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "University Medical Center Groningen",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "Hospital Duran i Reynals",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital General Universitario Gregorio Mara\u00f1n (Madrid)",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Complejo Hospitalario de Navarra",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Fundacio Investigao Hospital General Universitario de Valencia",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015266",
                    "term": "Carcinoma, Merkel Cell"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000027601",
                    "term": "Polyomavirus Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000014412",
                    "term": "Tumor Virus Infections"
                },
                {
                    "id": "D000018278",
                    "term": "Carcinoma, Neuroendocrine"
                },
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17967",
                    "name": "Carcinoma, Merkel Cell",
                    "asFound": "Merkel Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23236",
                    "name": "Polyomavirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17162",
                    "name": "Tumor Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M20423",
                    "name": "Carcinoma, Neuroendocrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T3716",
                    "name": "Merkel Cell Carcinoma",
                    "asFound": "Merkel Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000609138",
                    "term": "Avelumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M344580",
                    "name": "Avelumab",
                    "asFound": "Max",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M21134",
                    "name": "Antibodies, Blocking",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}